In our study, we measured serum and ascitic fluid SOD and MDA levels in patients with LC and serum SOD and MDA levels in control subjects to investigate the effect of severity of liver damage and SBP on these levels. This evidence concerns the gene SOD1 and laryngotracheoesophageal cleft.